Publications by authors named "Miriam Hock"

Claim this Profile
M
Molecular basis underpinning MR1 allomorph recognition by an MR1-restricted T cell receptor.
Richard J Suckling, Cevriye Pamukcu, Robert Alan Simmons, Daniel Fonseca, Emma Grant, Miriam Hock

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadening alloselectivity of T cell receptors by structure guided engineering.
Vijaykumar Karuppiah, Dhaval Sangani, Lorraine Whaley, Robert Pengelly, Pelin Uluocak, Miriam Hock

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral sequence determines HLA-E-restricted T cell recognition of hepatitis B surface antigen.
Gavuthami Murugesan, Rachel L Paterson, Rakesh Kulkarni, Veronica Ilkow, Richard J Suckling, Miriam Hock

Nat Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.
Andrew Chancellor, Robert Alan Simmons, Rahul C Khanolkar, Vladimir Nosi, Aisha Beshirova, Miriam Hock

J Exp Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic high affinity T cell receptor targeting a KRAS cancer neoantigen.
Andrew Poole, Vijaykumar Karuppiah, Annabelle Hartt, Jaafar N Haidar, Sylvie Moureau, Miriam Hock

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4.
Charlotte H Coles, Catriona McMurran, Angharad Lloyd, Miriam Hock, Linda Hibbert

J Biol Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA.
Christopher J Holland, Rory M Crean, Johanne M Pentier, Ben de Wet, Angharad Lloyd, Miriam Hock

J Clin Invest· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes.
Nika M Strokappe, Miriam Hock, Lucy Rutten, Laura E Mccoy, Jaap W Back

Antibodies (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
Rachel P J Lai, Miriam Hock, Jens Radzimanowski, Paul Tonks, David Lutje Hulsik

J Biol Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.
David Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, Simone Battella, Mohamed El Khattabi, Miriam Hock

PLoS Pathog· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA induced polymerization of the Borna disease virus nucleoprotein.
Miriam Hock, Ina Kraus, Guy Schoehn, Marc Jamin, Cornelia Andrei-Selmer

Virology· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis